Publications

Testimony

• August 25, 2009 Nanotechnology and Consumer Products CPSC Hearing Project Director David Rejeski’s Comments at the CPSC hearings David Rejeski
• April 24, 2008 Congressional Testimony - National Nanotechnology Initiative: Charting the Course for Reauthorization Senate Committee on Commerce, Science and Transportation-Subcommitte on Science, Technology, and Innovation New nanotechnology consumer products are coming on the market at the rate of three to four per week, a finding based on the latest update to the nanotechnology consumer product inventory. Today, in testimony before the U.S. Senate Committee on Commerce, Science & Transportation, PEN Project Director David Rejeski cited Ace Silver Plus—another of the nine nano toothpastes in the inventory—as an example of the upsurge in nanotechnology consumer products in stores. The hearing marks the start of U.S. Senate debate on the future direction of the annual $1.5 billion federal investment in nanotechnology research and development . David Rejeski
• April 16, 2008 House Science and Technology Committee’s hearing on the National Nanotechnology Initiative Amendments Act of 2008 Testimony of Dr. Andrew Maynard Today at the House Science and Technology Committee’s hearing on the National Nanotechnology Initiative Amendments Act of 2008, testimony highlighted shortfalls in the current U.S. Government Strategy. According to Dr. Andrew Maynard, without clear leadership and more transparency in federal risk research investment, the emergence of safe nanotechnologies will be a happy accident, rather than a foregone conclusion. Dr. Andrew Maynard
• October 10, 2006 Statement of Michael R. Taylor at FDA hearing Public Meeting on Nanotechnology Materials in FDA-Regulated Products Michael R. Taylor
• October 10, 2006 FDA and Nanotechnology: Public Perceptions Matter FDA Hearings Project Director David Rejeski’s Comments at the FDA hearings David Rejeski
• October 5, 2006 FDA-Regulated Products Containing Nanotechnology Materials Submission Update David Rejeski
• September 28, 2006 Comments on the UK Government’s response to the Royal Society and Royal Academy of Engineering report Nanoscience and nanotechnologies: opportunities and uncertainties The Project on Emerging Nanotechnologies has submitted comments on the United Kingdom (UK) Government’s response to the Royal Society and Royal Academy of Engineering report “Nanoscience and nanotechnologies: opportunities and uncertainties.” David Rejeski
• September 21, 2006 Testimony in front of the U.S. House of Representatives Committee on Science Research on Environmental and Safety Impacts of Nanotechnology: What are the Federal Agencies Doing? Andrew Maynard
• July 19, 2006 FDA-Regulated products containing nanotechnology materials Initial Project Submission to FDA hearings David Rejeski
• May 4, 2006 Testimony for the United States Senate Committee on Commerce, Science and Transportation Hearing on Promoting Economic Development Opportunities Through Nano Commercialization David Rejeski